|
LLPH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.369800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.248600E-01 |
| Normal-vs-Stage2 |
7.404600E-01 |
| Normal-vs-Stage3 |
6.311900E-02 |
| Normal-vs-Stage4 |
7.850200E-02 |
| Stage1-vs-Stage2 |
8.276200E-01 |
| Stage1-vs-Stage3 |
1.164250E-01 |
| Stage1-vs-Stage4 |
4.253000E-01 |
| Stage2-vs-Stage3 |
2.177600E-01 |
| Stage2-vs-Stage4 |
3.571800E-01 |
| Stage3-vs-Stage4 |
8.261000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.512400E-01 |
| Normal-vs-AfricanAmerican |
7.631700E-02 |
| Normal-vs-Asian |
2.507000E-01 |
| Caucasian-vs-AfricanAmerican |
4.785000E-01 |
| Caucasian-vs-Asian |
1.925030E-01 |
| AfricanAmerican-vs-Asian |
2.826000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.223800E-01 |
| Normal-vs-Female |
1.435270E-03 |
| Male-vs-Female |
3.023600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.433800E-01 |
| Normal-vs-Extreme_Weight |
7.348200E-01 |
| Normal-vs-Obese |
1.951560E-01 |
| Normal-vs-Extreme_Obese |
4.846400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.059600E-01 |
| Normal_Weight-vs-Obese |
8.025200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.469600E-01 |
| Extreme_Weight-vs-Obese |
3.572400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.385000E-01 |
| Obese-vs-Extreme_Obese |
1.988780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.564800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.728000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.879000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.775600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.155100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.044970E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.338600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.813990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.764000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.989600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.187570E-01 |
| Normal-VS-Type2 PRCC |
6.377000E-01 |
| Normal-VS-KIRP CIMP |
6.555700E-03 |
| Normal-VS-Unclassified PRCC |
2.598800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.202000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.320000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.578400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.124460E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.738800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.871900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.719600E-01 |
| Normal-vs-N1 |
8.137500E-03 |
| Normal-vs-N2 |
6.306200E-01 |
| N0-vs-N1 |
5.220200E-03 |
| N0-vs-N2 |
3.907600E-01 |
| N1-vs-N2 |
5.161800E-01 |
|
|
